Special Issues
Table of Content

Melatonin and Mitochondria: Exploring New Frontiers

Submission Deadline: 01 September 2025 (closed) View: 2895 Submit to Journal

Guest Editors

Russel J. Reiter (Honorary Guest Editor)

Email: reiter@uthscsa.edu

Affiliation: Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA

Homepage:

Research Interests: melatonin, free radicals of disease processes and aging, oxygen derivatives, neurodegenerative diseases


Doris Loh (Managing Guest Editor)

Email: lohdoris23@gmail.com

Affiliation: Independent Researcher, Marble Falls, TX, USA

Homepage:

Research Interests: melatonin, ascorbic acid, aging, mitochondria, biomolecular condensates


Summary

Melatonin, an ancient and evolutionarily successful indoleamine, first appeared in Archaea and Bacteria approximately 4 billion years ago. It has since been identified as a ubiquitous molecule in the mitochondria and chloroplasts of tested Eukarya species, regardless of the presence of a pineal gland. Current scientific consensus suggests that mitochondrial melatonin accounts for over 95% of total organismal melatonin production, highlighting the diverse pleiotropic effects of this compound in various biological systems.

 

In plants and unicellular organisms, melatonin production is highly responsive to both endogenous and exogenous stress, suggesting its role as a protective agent. However, the relationship between mitochondrial melatonin production and pineal melatonin synthesis under cellular stress remains poorly understood. Of particular importance is the realization that many experimental models, including inbred rodents and transgenic animals, exhibit reduced circulating melatonin due to truncated AANAT (SNAT) genes in their mitochondria, potentially complicating the interpretation of findings in fields such as oncology, neurobiology, and other areas of health and disease research.

 

This special issue aims to delve into the intriguing roles of mitochondrial melatonin beyond the pineal gland, with a focus on how it may interact with pineal melatonin in maintaining cellular homeostasis and mitigating disease. We seek to explore how mitochondrial melatonin influences various biological processes and how these innovative insights might open up new therapeutic avenues for treating conditions such as neurodegenerative diseases, metabolic disorders, and cancer.

 

Key areas of focus include, but are not limited to:

1. Oxidative Phosphorylation and ATP Synthesis:

   - Investigating how mitochondrial melatonin regulates oxidative phosphorylation and energy production.

2. Mitochondrial Bioenergetics, Dynamics, Morphology, and Proteostasis:

   - Exploring the role of melatonin in maintaining mitochondrial structure and function, including the regulation of mitochondrial fission, fusion, autophagy, and cristae architecture.

3. Mitochondrial Transcription and Translation:

   - Understanding how melatonin influences mitochondrial gene expression and protein synthesis, particularly in response to cellular stress or damage.

 

By compiling cutting-edge research on these topics, this special issue will provide a deeper understanding of the functions of mitochondrial melatonin and its potential applications in health and disease. We invite original research articles, reviews, and perspectives that advance knowledge on this topic and contribute to shaping future research directions in the field.


Keywords

melatonin, mitochondria, oxidative phosphorylation, bioenergetics, mitochondrial dynamics, proteostasis, transcription, translation, neurodegenerative diseases, metabolic syndromes, cancer, cellular stress

Published Papers


  • Open Access

    REVIEW

    Melatonin and Mitochondrial Function: Insights into Bioenergetics, Dynamics, and Gene Regulation

    Silvia Carloni, Maria Gemma Nasoni, Serafina Perrone, Erik Bargagni, Carla Gentile, Walter Manucha, Russel J. Reiter, Francesca Luchetti, Walter Balduini
    BIOCELL, DOI:10.32604/biocell.2025.073776
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract Mitochondria are central regulators of cellular energy metabolism, redox balance, and survival, and their dysfunction contributes to neurodegenerative, cardiovascular, and metabolic diseases, as well as aging. Beyond its role as a circadian hormone, melatonin is now recognized as a key modulator of mitochondrial physiology. This review provides an overview of the mechanisms by which melatonin can preserve mitochondrial function through multifaceted mechanisms. Experimental evidence shows that melatonin enhances the activity of electron transport chain (ETC) complexes, stabilizes the mitochondrial membrane potential (Δψ), and prevents cardiolipin (CL) peroxidation, thereby limiting permeability transition pore (mPTP) opening and… More >

  • Open Access

    ARTICLE

    Melatonin and Related Compounds as Enzymatic Antioxidants: A Comprehensive Theoretical Study

    Luis Felipe HernáNdez-Ayala, Russel J. Reiter, Annia Galano
    BIOCELL, DOI:10.32604/biocell.2025.071635
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract Objectives: Oxidative stress (OS) plays a pivotal role in chronic and neurodegenerative diseases, which has sparked interest in molecules that modulate redox-regulating enzymes. Melatonin and its metabolites exhibit antioxidant properties; however, their molecular mechanisms of enzymatic and transcriptional modulation remain unclear. This study aimed to investigate, through an exploratory in silico approach, the interactions of melatonin and related compounds with OS-related enzymes to generate hypotheses about their role in cellular redox control. Methods: A rational selection of antioxidant, pro-oxidant, and transcriptional targets was performed. Ligands were optimized at the DFT level (M05-2X/6-311+G(d,p)) and docked to OS… More >

  • Open Access

    REVIEW

    Melatonin as a Neuroprotective Agent in Ischemic Stroke: Mechanistic Insights Centralizing Mitochondria as a Potential Therapeutic Target

    Mayuri Shukla, Soraya Boonmag, Parichart Boontem, Piyarat Govitrapong
    BIOCELL, DOI:10.32604/biocell.2025.072557
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract Ischemic stroke is one of the major causes of long-term disability and mortality worldwide. It results from an interruption in the cerebral blood flow, triggering a cascade of detrimental events like oxidative stress, mitochondrial dysfunction, neuroinflammation, excitotoxicity, and apoptosis, causing neuronal injury and cellular death. Melatonin, a pleiotropic indoleamine produced by the pineal gland, has multifaceted neuroprotective effects on stroke pathophysiology. Interestingly, the serum melatonin levels are associated with peroxidation and antioxidant status, along with mortality score in patients with severe middle cerebral artery infarction. Melatonin exhibits strong antioxidant, anti-inflammatory, and anti-apoptotic properties and preserves More >

  • Open Access

    REVIEW

    The Warburg Effect Beyond Cancer: Melatonin as a Metabolic Modulator in Non-Neoplastic Disorders

    JOSé A. BOGA, ANA COTO-MONTES, RUSSEL J. REITER
    BIOCELL, DOI:10.32604/biocell.2025.068245
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract Aerobic glycolysis, also known as the Warburg effect, and the accumulation of lactate that it causes, are increasingly recognized outside the field of oncology as triggers of chronic non-neoplastic disorders. This review integrates preclinical and clinical evidence to evaluate the ability of melatonin to reverse Warburg-effect-like metabolic reprogramming. Literature on neurodegeneration, age-related sarcopenia, type 2 diabetes, chronic kidney disease, heart failure and pulmonary arterial hypertension (PAH) has been reviewed and synthesised. In all of these conditions, hypoxia-inducible factor 1α (HIF-1α) and pyruvate dehydrogenase kinase 4 (PDK4) inhibit the pyruvate dehydrogenase complex. This diverts pyruvate away… More >

  • Open Access

    REVIEW

    Mitochondrial Stress, Melatonin, and Neurodegenerative Diseases: New Nanopharmacological Approaches

    Virna Margarita Martín Giménez, SebastiáN GarcíA MenéNdez, Luiz Gustavo A. Chuffa, Vinicius Augusto SimãO, Russel J. Reiter, Ramaswamy Sharma, Walter Balduini, Carla Gentile, Walter Manucha
    BIOCELL, DOI:10.32604/biocell.2025.071830
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract Neurodegenerative diseases (NDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) are characterized by progressive neuronal loss, which is closely linked to mitochondrial dysfunction. These pathologies involve a complex interplay of genetics, protein misfolding, and cellular stress, culminating in impaired energy metabolism, an increase in reactive oxygen species (ROS), and defective mitochondrial quality control. The accumulation of damaged mitochondria and dysregulation of pathways such as the Integrated Stress Response (ISR) are central to the pathogenesis of these conditions. This review explores the critical relationship between mitochondrial stress… More >

  • Open Access

    REVIEW

    Mechanistic Insights into the Role of Melatonin in Cancer Cell Chemoresistance

    Russel J. Reiter, Ramaswamy Sharma, Walter Manucha, Walter Balduini, Doris Loh, Demetrios A. Spandidos, Alejandro Romero, Vasiliki E. Georgakopoulou, Wei Zhu
    BIOCELL, Vol.49, No.11, pp. 2033-2067, 2025, DOI:10.32604/biocell.2025.067661
    (This article belongs to the Special Issue: Melatonin and Mitochondria: Exploring New Frontiers)
    Abstract The development of cancer cell resistance to conventional treatments continues to be a major obstacle in the successful treatment of tumors of many types. The discovery of a highly efficient direct and indirect free radical scavenger, melatonin, in the mitochondrial matrix may be a factor in determining both the occurrence of cancer cell drug insensitivity as well as radioresistance. This relates to two of the known hallmarks of cancer, i.e., exaggerated free radical generation in the mitochondria and the development of Warburg type metabolism (glycolysis). The hypothesis elaborated in this report assumes that the high… More >

Share Link